PD-1 cooperates with AIRE-mediated tolerance to prevent lethal autoimmune disease.

Immunological tolerance is established and maintained by a diverse array of safeguards that work together to protect against autoimmunity. Despite the identification of numerous tolerogenic processes, the basis for cooperation among them remains poorly understood. We sought to identify synergy among several well-defined tolerance mediators that alone provide protection only from mild autoimmune symptoms in C57BL/6 mice: BIM, AIRE, CBL-B, and PD-1. Survey of a range of compound mutant mice revealed that the combined loss of the autoimmune regulator, AIRE, with PD-1 unleashed a spontaneous, lethal autoimmune disease. Pdcd1−/−Aire−/− mice succumbed to cachexia before adulthood, with near-complete destruction of the exocrine pancreas. Such fatal autoimmunity was not observed in Pdcd1−/−Bim−/−, Bim−/−Aire−/−, or Cblb−/−Bim−/− mice, suggesting that the cooperation between AIRE-mediated and PD-1–mediated tolerance was particularly potent. Immune profiling revealed largely normal development of FOXP3+ regulatory T (Treg) cells in Pdcd1−/−Aire−/− mice, yet excessive, early activation of effector T cells. Adoptive transfer experiments demonstrated that autoimmune exocrine pancreatitis was driven by conventional CD4+ T cells and could not be prevented by the cotransfer of Treg cells from wild-type mice. The development of autoimmunity in mixed bone marrow chimeras supported these observations, indicating that failure of recessive tolerance was responsible for disease. These findings reveal a potent tolerogenic axis between AIRE and PD-1 that has implications for our understanding of how immune checkpoint blockade might synergize with subclinical defects in central tolerance to elicit autoimmune disease.

Autoimmune disease develops in ∼3% of the US population, typically after a long period of latency (1). A variety of immunological tolerance mechanisms orchestrate the removal or silencing of autoreactive lymphocytes to prevent tissue damage (2, 3). The long latency for development of autoimmune pathology has led to suggestions that serial breakdown of multiple immune tolerance mechanisms (or checkpoints) must occur for overt disease to become apparent (3).

T cell tolerance is imposed in two main locations. The first location is the thymus, where a variety of mechanisms delete or censor highly autoreactive clones during the differentiation of T cells. These processes are collectively referred to as thymic negative selection (4, 5). For example, the proapoptotic BH3-only protein, BIM, is required for the deletion of self-reactive thymocytes receiving high-avidity T cell receptor (TCR) signals; yet Bim−/− mice on the C57BL/6 background only develop mild autoimmune symptoms (6, 7). Similarly, C57BL/6.Aire−/− mice have impaired negative selection of thymocytes reactive to peripheral tissue antigens (PTA) normally produced by the thymic epithelium; yet they also only develop relatively mild autoimmune symptoms (8, 9). These findings reinforce the notion that additional tolerance mechanisms act as fail-safes to control autoreactive T cells when thymic deletion is impaired.

Mature T cells that are exported from the thymus to peripheral lymphoid and nonlymphoid organs are subject to peripheral tolerance mechanisms, such as deletion, anergy, inhibitory receptor engagement, or suppression by regulatory cells (10). The ubiquitin ligase, CBL-B, can enforce anergy and restrain the activation of autoreactive T cells by imposing the requirement for CD28 costimulation (11, 12). By contrast, ligation of the inhibitory receptor, PD-1, antagonizes activated T cell responses and curtails spontaneous autoimmunity in certain contexts (13, 14). However, in these and many other examples, the loss of individual tolerance genes does not elicit catastrophic autoimmune disease in C57BL/6 mice. This observation supports the hypothesis that there must exist a substantial degree of cooperation among the various tolerance processes preventing autoimmune disease. Yet the most critical components of this cooperation remain unclear.

Although the concept that peripheral tolerance provides an essential backup to when thymic negative selection fails is well established, examples of the mechanisms underpinning this interaction are surprisingly few. One example is provided by Aire mice on the B10.Br background, which develop fatal autoimmune pancreatitis and sialitis that was not observed with deficiency of either gene alone (15). In this case, CBL-B was required to antagonize peripheral activation of autoreactive T cells escaping AIRE-dependent thymic deletion. By contrast, compound mutant Aire−/− mice also lacking FASL, Roquin, or CARD11 revealed no cooperation between these tolerance mechanisms (15). Due to the paucity of information on further cooperativity among the distinct tolerance mechanisms, we generated mice with genetic deletion of key central and peripheral tolerance mediators to uncover critical interactions between different tolerance-inducing processes.

PD-1 is notable in this context because it is an important target in cancer immunotherapies that overcome immune inhibition to promote tumor cell killing. However, these responses are often attended by autoimmune side effects. Initial evidence that PD-1 plays a role in immunological tolerance came from mice lacking Pdcd1 (the gene encoding PD-1) which, on a C57BL/6 genetic background, exhibit spontaneous development of a late-onset, lupus-like disease characterized by autoantibodies and mild glomerulonephritis (13). This tolerance defect was exacerbated on autoimmune-prone backgrounds, such BALB/c, where Pdcd1 deficiency induced fatal myocarditis and gastritis (13). These studies indicate that the PD-1–mediated immune suppressive pathway plays a critical role in maintaining immunological tolerance. PD-1 appears to control peripheral tolerance by limiting the initial phase of activation and expansion of self-reactive T cells, and restricts self-reactive T cell effector functions in the nonlymphoid tissues of perinatal mice (16). Thus, the adverse immune events observed in patients receiving PD-1 or PD-L1 blocking agents could reflect manifestations that have their origin in defects in central tolerance mechanisms. We sought to investigate the impact of interfering simultaneously with central and peripheral tolerance mechanisms to uncover critical synergies that may inform on the best combinations for new treatment strategies and on the mechanisms of toxicity from currently used immunotherapies.

Results

Pd1 Compound-Deficient Mice Succumb to Fatal Exocrine Pancreatitis.

To investigate the cooperation between central and peripheral tolerance mechanisms, we took a genetic loss-of-function approach. BIM and AIRE are critical mediators of thymic negative selection that act via distinct mechanisms. BIM is a proapoptotic protein required for the killing of thymocytes that receive high-avidity TCR signals (6). On a C57BL/6 background, Bim mice develop features of systemic lupus erythematosus but do not succumb to organ-specific autoimmunity (7). AIRE is required for the expression of PTAs by thymic epithelial cells, and defects in this process lead to autoimmunity in a range of organs (8, 9). The presentation of AIRE-regulated PTAs on thymic epithelial cells or dendritic cells is required to mediate deletion of thymocytes with autoreactive TCRs or Treg cell generation (5). To test whether AIRE and BIM activities overlap in the induction of thymic tolerance or are distinct, we aged cohorts of Aire−/−, Bim−/−, and Bim−/−;Aire−/− mice and examined the impact on organ-specific autoimmunity. All mice in these groups survived to the 150-d end point of the experiment (Fig. 1), whereupon histological analysis was undertaken in organs normally targeted by autoimmune manifestations in Aire−/− or Bim−/− mice. Bim−/−;Aire−/− mice exhibited the autoimmune features frequently observed in AIRE-deficient mice (i.e., severe retinopathy, sialitis, mild pneumonitis, lacrimal gland infiltration), combined with the mild renal pathology that is associated with BIM deficiency (Fig. 1 and ). For further comparison, we performed a semiquantitative assessment of lymphocytic infiltration and tissue destruction in all organs and summed these values into an overall “autoimmunity score” (7, 9) (an example is shown for pancreas in ). We found that the average overall score in Bim−/−;Aire−/− mice was effectively the sum of those observed in the groups of Aire−/− or Bim−/− mice (Fig. 1), suggesting that the tolerogenic defects induced by the compound loss of BIM and AIRE were additive (Fig. 1). The relatively mild impact of these combined defects in negative selection suggests that peripheral tolerance mechanisms are sufficient to prevent the activation of autoreactive T cells and the development of severe autoimmune disease.

Fig. 1.

Autoimmune pathology resulting from combined defects in peripheral and central tolerance mechanisms. (A) Survival of Bim, Pdcd1−/−, Bim, Cblb, Pdcd1−/−;Bim, and Pdcd1−/−;Aire mice (all on a C57BL/6 background). (B) Representative images of H&E-stained sections of the pancreas, eye, kidney, and lacrimal gland from mice of the indicated genotypes taken at 150 d. (Scale bar, 500 μm.) (C) Combined “autoimmunity score” for the various mouse strains, summing infiltration/destruction scores from the major organs of the mice indicated (n = 3 to 12). (D) Representative images of H&E-stained sections of the indicated organs taken from Pdcd1−/−;Aire mice upon euthanasia. Black arrows indicate examples of lymphocytic infiltration. (Scale bar, 500 μm.)

To explore peripheral tolerance mechanisms that may be important for preserving tolerance when thymic tolerance is perturbed, we genetically ablated Pdcd1 or Cblb in conjunction with either Bim or Aire. All single- or double-knockout mice survived until the end of the experiment (150 d), except those with a combined deficiency of Pdcd1 and Aire (Fig. 1). These Pdcd1 mice became runted and died at weaning. Comparative histological analysis of organs from those mice surviving to 150 d showed that Cblb mice had much more severe infiltration and tissue destruction than the single-knockout controls (Fig. 1 ). It was previously reported that Cblb mice on a B10.BR background succumbed to fatal autoimmune disease with a median survival of 25 d (15). However, on the C57BL/6 background we tested here, we did not observe lethal autoimmune disease within 150 d of age (Fig. 1). Nevertheless, there was substantial leukocyte infiltration in the salivary gland, liver, retina, and pancreas; the latter is an organ that is not normally targeted in either of the single-mutant mice (Fig. 1 ). These data highlight the potent synergy between AIRE-mediated thymic tolerance and CBL-B–mediated peripheral tolerance.

In contrast to all other strains examined, Pdcd1; mice succumbed to a wasting disease at a young age (Fig. 1). Analysis of organs from 3-wk-old Pdcd1;Aire mice revealed substantial lymphocytic infiltration in the lung, salivary gland, liver, and retina and near-complete destruction of the pancreas (Fig. 1 and ). Extensive destruction of the exocrine acinar cells was evident, yet the islets of Langerhans were typically spared, and these mice did not develop diabetes (Fig. 1 and ). These results show that AIRE-dependent mechanisms synergize with CBL-B– or PD-1–dependent processes to safeguard immunological tolerance and prevent severe autoimmune disease.

Fatal Exocrine Pancreatitis in Pdcd1;Aire Mice Is Mediated by CD4+ T Cells.

We next sought to determine the basis of the fatal autoimmune disease observed in mice lacking both AIRE and PD-1. Flow cytometric analysis of splenocytes from Pdcd1;Aire compound mutant mice at 2.5 wk of age (just prior to the onset of lethal wasting) revealed an increased frequency and number of CD8+ T cells and FOXP3+ Treg cells compared to wild-type (WT), Pdcd1, and Pdcd1 mice of the same age (Fig. 2). CD4+ and CD8+ conventional T cells from mice lacking PD-1 and AIRE had markedly heightened activation compared to controls and Pdcd1 mice (Fig. 2). FOXP3+ Treg cells from young Pdcd1;Aire mice also showed signs of heightened activation, with an increase in cells with a CD44highCD62LlowICOS+FOXP3+ Treg effector phenotype (Fig. 2). These phenotypes are consistent with the autoimmune features observed being driven by loss of T cell tolerance.

Fig. 2.

Abnormally increased T cell activation in Pdcd-1−/−;Aire−/− mice. (A) Graphs of the mean percentages and total numbers (±SEM) of splenic CD4+ and CD8+ T cells and CD4+Foxp3+ Treg cells from 2.5-wk-old mice of the indicated genotypes. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001 Student’s t test. (B) CD44 and CD62L expression gated on CD4+ or CD8+ T cells from 19-d-old mice of the indicated genotypes. Percentages of naïve T cells and effector/memory T cells based on the indicated regions are shown. Data are representative of three individual experiments (n > 4 mice per genotype). (C) FOXP3 and CD25 expression in splenic CD4+ T cells (Top), CD44 and CD62L expression on splenic Foxp3+ CD4+ T cells (Middle), and ICOS expression on splenic Foxp3+ CD4+ T cells (Bottom) from mice of the indicated genotypes at 2.5 wk for Pdcd-1;Aire mice and at 8 wk for mice of the other genotypes. The percentages of the indicated regions are shown. Data in A–C are representative of three or four experiments performed with n = 3 to 6 per genotype.

To establish whether the diversity of the TCR repertoire was a driver of the fatal autoimmune disease of the Pdcd1 mice, we introduced the OT-I TCR transgene onto this background. OT-1 TCR tg mice have a restricted TCR repertoire, with most T cells bearing antigen receptors specific for an ovalbumin-derived peptide presented by H2-Kb. Therefore, we compared the survival of Pdcd1 mice with that of OT-I tg;Pdcd1 mice to determine whether reducing TCR repertoire diversity would impact the development of disease. Pdcd1 mice bearing the OT-I TCR transgene had substantially delayed disease development, with most animals surviving beyond 110 d (Fig. 3). These older OT-I tg;Pdcd1 mice succumbed to a wasting condition similar to the younger, nontransgenic Pdcd1 controls. These findings demonstrate that restricting the diversity of the TCR repertoire in Pdcd1 mice substantially delays the development of severe autoimmunity, further implicating autoreactive T cells as drivers of the disease.

Fig. 3.

Fatal exocrine pancreatitis in Pdcd-1 mice is driven by CD4+ T cells. (A) Survival of Pdcd1−/−, Pdcd1−/−;Bim−/−, and Pdcd1−/−;Aire−/− mice with or without the OT-1 TCR transgene. (B) Survival of Rag1 mice adoptively transferred with T cells from Pdcd1, or Pdcd-1 mice or with purified CD4+ or CD8+ cells from Pdcd1 mice. (C) Histological analysis of sections of the pancreas from Rag1 mice that had been injected i.v. with total T cells from Pdcd1−/− or Pdcd1 mice. (Scale bar, 500 μm.) (D) Representative flow cytometric analysis of splenocytes from Rag1 mice that had been injected i.v. with purified CD4+ T cells from WT, Pdcd1−/−, or Pdcd1 mice. The percentage of naive/activated T cells (Top) or Treg cells (Bottom) bounded by region gating are shown. Data are representative of two experiments performed with three to five mice per group.

We next performed adoptive transfers of T cells from PD-1–deficient and AIRE-deficient mice into Rag1 recipients to test whether this population was sufficient to induce disease. Previous studies have established that mature lymphocytes from Aire−/− mice can transfer mild autoimmunity in Rag1−/− recipients, but do not cause early lethality (8). By contrast, all Rag1 mice that we had inoculated with T cells from Pdcd1 animals died within 5 wk, presenting with severe weight loss and extensive destruction of pancreatic acinar cells (Fig. 3 ). Flow cytometric analysis of these animals revealed greatly increased CD44high CD62Llow activated/memory T cells (Fig. 3), similar to the phenotype observed in the intact Pdcd1 mice. Rag1−/− mice receiving T cells from mice lacking only PD-1 also had increased activated/memory T cells, but they remained healthy for 150 d and did not display any signs of autoimmune pancreatitis (Fig. 3 ). These outcomes indicate that autoreactive T cells are sufficient to drive the fatal exocrine pancreatitis observed in Pdcd1−/−;Aire−/− mice. Furthermore, although PD-1–deficient T cells can become activated in lymphopenic recipients, AIRE-mediated thymic tolerance likely curtails the autoreactive repertoire and prevents the lethal autoimmunity.

To determine whether CD4+ or CD8+ T cells from Pdcd1−/−;Aire−/− mice were the key autoimmune effectors, these populations were enriched and injected separately into Rag1 mice. Residual contaminating CD8+ or CD4+ cells were depleted with anti-CD4 or anti-CD8 antibodies in the recipients. Only recipients of CD4+ T cells from Pdcd1 mice succumbed to autoimmune pancreatitis within 4 wk, whereas the mice that had been injected with CD8+ T cells remained healthy to at least 150 d following transfer (Fig. 3). These findings demonstrate that the fatal autoimmune destruction of the exocrine pancreas in Pdcd1 mice is driven by a breakdown of tolerance in CD4+ T cells.

Cell-Intrinsic Tolerance Defects in Pdcd1 Mice Drive Fatal Autoimmunity.

The CD4+ population includes immune-suppressive FOXP3+ Treg cells. Treg cells express high levels of PD-1 which functions to restrain their differentiation and suppressive function (17). Nevertheless, it remained possible that the additional loss of AIRE modified the capacity of PD-1–deficient Treg cells to suppress autoimmune responses. Therefore, we sought to determine whether the impaired tolerance observed in Pdcd1 mice stemmed from defects in recessive (cell intrinsic) or dominant (cell extrinsic) mechanisms of tolerance. The suppressive capacity of Treg cells from Pdcd1 was comparable to that of WT Treg cells (), indicating that there was not a gross functional defect in PD-1–deficient Treg cells. Cotransfer of Treg cells from WT mice with CD4+ T cells taken from Pdcd1−/−;Aire−/− mice into Rag1−/− mice () did not rescue these recipients from lethal autoimmune disease (Fig. 4). This finding suggests that the breakdown in tolerance observed in PD-1/AIRE compound mutant mice was not due to defects in Treg cell function.

Fig. 4.

A cell-intrinsic requirement for PD-1 to prevent autoimmunity in AIRE-deficient mice. (A) Survival of Rag1 mice adoptively transferred with T cells from Pdcd-1 mice with or without coadministration of CD4+Foxp3+ Treg cells from WT mice. (B) Survival of WT or Aire hematopoietic chimeras reconstituted with bone marrow cells from WT, Pdcd-1, or a 50:50 mixture of both. (C) Representative histograms of PD-1 expression on splenic CD4+ FOXP3− T cells from Aire+/+ (WT) or Aire−/− mice. Right quantify the mean percentage (±SEM) of PD-1+ Tconv or Treg cells from Aire+/+ (WT) or Aire−/− mice. **P < 0.01, ****P < 0.0001 Student’s t test. Data in C are representative of two experiments, each with n = 5 mice per group.

To investigate the possibility that defects in other immunoregulatory hematopoietic cell types were the basis of autoimmune disease in Pdcd1−/−;Aire−/− mice, we established mixed hematopoietic chimeras in lethally irradiated WT or Aire recipient mice with donor cells from WT and PD-1–deficient mice. Mice were then analyzed for the onset of lethal autoimmunity, to test whether the presence of WT T cells could impose tolerance on PD-1–deficient T cells “educated” in an AIRE-deficient thymus. Controls included irradiated WT or Aire−/− mice receiving only WT or only PD-1–deficient bone marrow cells, respectively. As expected, Ly5.2 WT mice reconstituted with 100% Ly5.1 WT bone marrow cells remained healthy, whereas Aire mice reconstituted with 100% bone marrow cells from Pdcd1 mice swiftly succumbed to a wasting disease with a similar latency as mice with combined germline deletion of both AIRE and PD-1 (Fig. 4). A fraction of control WT mice that had been reconstituted with either 100% bone marrow cells from Pdcd1 mice or a 1:1 mixture of WT and PD-1–deficient bone marrow cells developed wasting disease with a delayed onset (Fig. 4). This finding suggested a degree of autoimmunity in this setting, consistent with previous findings in Pdcd1→Rag1−/− chimeras (18), and that this disease could not be inhibited by WT hematopoietic cells. Aire mice reconstituted with a 1:1 mixture of WT and PD-1–deficient bone marrow cells died within 6 wk of transplantation, with histological analysis revealing severe autoimmune destruction of the pancreas to the same extent as that observed in the intact Pdcd1 mice (). These findings establish that PD-1 deficiency in the hematopoietic compartment and AIRE deficiency in the stromal compartment is sufficient to induce lethal autoimmunity in mice. Furthermore, the breakdown in immunological tolerance observed in Pdcd1 mice could not be corrected by complementation with WT cells, indicating that defects in recessive tolerance drive autoimmunity in this setting.

Previous studies using transgenic systems have found roles for PD-1 in thymic beta and positive selection events (19–21). To determine whether PD-1 may also play a role in thymic deletion in the polyclonal setting, we used an approach developed by Breed et al. (22) to quantify thymocytes undergoing deletion using cleaved (i.e., activated) caspase-3 (). As expected, genetic loss of the apoptotic effector proteins BAX and BAK reduced clonal deletion in thymocytes, and BIM accounted for much of this activity (). The loss of AIRE did not change the proportion of deleted cells, suggesting this assay is not sensitive enough to detect the deletion of those thymocytes reactive to PTA (). Similar levels of apoptotic thymocytes were detected in Pdcd1 mice and WT controls (), suggesting that PD-1 does not grossly affect thymic deletion, at least within the dynamic range of this assay.

Collectively, these data are consistent with a scenario where increased numbers of autoreactive T cells emerge from the thymus of AIRE-deficient mice which are then restrained by PD-1–mediated signals. In accord with this notion, we found an increased proportion of splenic PD-1+ Tconv and Treg cells in Aire−/− mice (Fig. 4).

Discussion

It has been proposed that multiple mechanisms of immune tolerance must fail for autoimmune pathology to ensue (3). However, there are few examples highlighting cooperation among the various mechanisms imposing tolerance. The current study adds to our understanding by identifying cooperation between key central and peripheral tolerance mechanisms that prevent severe autoimmune pathology. We find that the loss of AIRE alone does not result in severe autoimmunity on the C57BL/6 background, because peripheral tolerance mechanisms restrain the activation of the autoreactive cells that have escaped the thymus. We confirm a key role for the ubiquitin ligase, CBL-B, in maintaining T cell tolerance in Aire−/− mice (15), with Cblb−/−;Aire−/− mice developing multiple signs of organ-specific autoimmunity. Although autoimmunity in Cblb−/−;Aire−/− mice on the B10.Br background was fatal, we found that, on the relatively autoimmune-resistant C57BL/6 background, they can survive well into adulthood. By contrast, PD-1 expression in Aire−/− mice was essential for preventing an early onset, fulminant, and lethal autoimmune disease. Together, these findings reveal potent synergy between AIRE-mediated thymic tolerance and certain peripheral mechanisms that restrain T cell activation.

The rapid, multiorgan, fatal autoimmune disease we found in Pdcd1 mice was caused by defective recessive tolerance in CD4+ T cells. Treg cells from WT mice could not restrain autoreactive T cells from PD-1 and AIRE double-deficient mice, nor were mixed bone marrow chimeras able to maintain tolerance. The primary role for pathogenic CD4+ T cells echoes findings with PD-1–deficient cell reconstitution and T cell transfer studies in lymphopenic Rag1−/− mice (18, 23) and the effector cells responsible for autoimmunity in Aire−/− mice (24). The PD-1 ligands, PD-L1 and PD-L2, are expressed on thymic stromal cells (25), and roles for PD-1 in thymocyte selection have been reported in some systems (19–21). We did not find evidence of gross impacts on thymic deletion in nontransgenic Pdcd1−/− mice; however, we cannot exclude that there may be a subtle role for PD-1 in thymic selection that contributes to the autoimmune phenotype in Pdcd1−/−Aire−/− mice. Nevertheless, given the preponderance of evidence that PD-1 plays critical roles in preserving peripheral tolerance, we favor the hypothesis that autoreactive T cells specific for AIRE-regulated self-antigens that escape from the thymus are normally held in check by PD-1–mediated anergy. Consistent with this notion, we found elevated PD-1 expression in T cells from Aire−/− mice.

It was also recently found that high PD-1 expression was a characteristic of T cells infiltrating the nonlymphoid tissues of perinatal AIRE-deficient mice (16). It is well established that the perinatal stage is the critical time window for the establishment of AIRE-mediated tolerance (26). PD-1 antibody blockade in NOD.Aire−/− mice triggered early multiorgan autoimmunity, including the exocrine pancreatitis that is characteristic of this background (9, 16). These findings demonstrate an important role for PD-1 in establishing and maintaining an anergic phenotype in tissue-infiltrating T cells specific for AIRE-regulated antigens that have egressed from the perinatal thymus and are consistent with the early onset of the lethal autoimmune disease we describe here.

Therefore, the picture that emerges is that AIRE-dependent thymic tolerance acts to reduce the number of autoreactive cells emerging into the periphery, while PD-1 antagonizes the activation/effector function of any autoreactive clones that somehow escape from the thymus into the periphery. The efficiency of thymic selection is likely to vary in the population due to a range of factors, such as variation in AIRE expression, polymorphisms at HLA or specific PTA loci that affect thymic presentation, and differences in the efficiency of apoptotic deletion of autoreactive cells (27). An implication of the concept that PD-1–mediated peripheral tolerance is essential for supporting central tolerance is that individuals at the lower range of effective thymic tolerance may be at greater risk of adverse immune events from therapies blocking PDL1/PD-1 interactions. Indeed, pancreatitis has been observed as an immune-mediated adverse effect during cancer immunotherapy (28–30). Conversely, patients with lower thymic selection thresholds might also initiate better anticancer responses during immunotherapy. A study of a small number of melanoma patients receiving the CTLA-4 antagonist, ipilimumab, found associations between AIRE polymorphisms and treatment outcomes (31). Certainly, in animal models, there is evidence that constitutive or transient AIRE deficiency can improve antimelanoma responses (32, 33), particularly in concert with CTLA-4 blockade (31). The outcome of a clinical trial of the combination of PD-1 blockade (with or without CTLA-4 blockade) and RANK-L inhibition for the treatment of metastatic melanoma will be an interesting test of this idea (NCT03161756).

Compound deficiency in two key mediators of thymic negative selection, BIM and AIRE, did not elicit fatal autoimmune disease in C57BL/6 mice. This finding suggests that peripheral tolerance mechanisms remain capable of controlling the increased burden of autoreactive cells emerging from severe, compound defects in thymic negative selection. To put it another way, thymocyte deletion may be dispensable for immunological tolerance, since PD-1– and/or CBL-B–mediated mechanisms can control pathological autoreactive T cell responses, at least on the C57BL/6 genetic background. One caveat is that other proapoptotic proteins can contribute to thymic deletion processes in addition to BIM [e.g., PUMA (7)]; therefore, further defects on thymic negative selection might induce autoimmunity. Nevertheless, our data suggest that synergy between central and peripheral tolerance mechanisms are more potent than cooperation between different central tolerance mechanisms.

In this context, it was somewhat surprising that mice deficient in both BIM and PD-1 did not display overt signs of autoimmune disease, unlike Pdcd1−/−;Aire−/− animals. BIM is responsible for the apoptotic deletion of many autoreactive thymocytes (6, 22). This role extends to many thymocytes expressing TCRs recognizing self-antigens that are AIRE dependent (although not all; the related BH3-only protein, PUMA, is also required for efficient deletion of PTA-reactive thymocytes) (7). However, one important distinction between the T cells emerging from the thymus of Aire−/− and Bim−/− mice is that only in the latter are thymocytes likely to have encountered their cognate self-antigen during selection (e.g., ref. 34). Therefore, antigen experience in the thymus may induce other central tolerance mechanisms, such as anergy or diversion into the Treg cell lineage. Indeed, Bim−/− mice exhibit a large expansion of the FOXP3+ Treg cell population (35, 36) that is not observed in Aire−/− mice, perhaps further buttressing peripheral tolerance mechanisms, even in the absence of PD-1.

In conclusion, this study identifies a potent tolerogenic axis between AIRE-mediated thymic tolerance and PD-1–mediated control of autoreactive T cell responses. Conversely, defective BIM-mediated apoptosis did not synergize with AIRE-mediated or CBL-B– or PD-1–mediated tolerance mechanisms. These findings highlight the importance of AIRE function as a factor influencing responses to immunotherapy.

Materials and Methods

Mice.

All mice were housed at Walter and Eliza Hall Institute (WEHI) under specific pathogen-free housing conditions, and experiments were carried out in accordance with the guidelines and requirements of the Walter and Eliza Hall Research Animal Ethics Committee. Bim−/− mice (Bcl2l11−/−) were generated on a mixed C57BL/6 × 129SV background (37) and were then backcrossed to the C57BL/6 background >20 times prior to their use in intercrosses for this study (7). OT-1 TCR transgenic mice generated on a C57BL/6 genetic background have been described (38), and Rag1J and Ly5.1 on a C57BL/6 background mice were obtained from WEHI Bioservices. Pdcd1−/− mice were obtained from Arlene Sharpe, Harvard Medical School, Cambridge, MA, and backcrossed to the C57BL/6 background. Cblb mice on a C57BL/6 background were obtained from Chris Goodnow, Garvan Institute for Medical Research, Darlinghurst, NSW, Australia. Aire (8) and Bak−/− BaxΔCd4 mice (39) were generated as described and maintained on a C57BL/6 background.

Bone Marrow Reconstitution Experiments.

Recipient mice were irradiated with two doses of 5.5 Gy 3 h apart prior to injection of donor cells. The hind legs of donor mice were dissected, and the bone marrow was flushed into cold fluorescence-activated cell sorter buffer (phosphate-buffered saline [PBS] containing 2% fetal calf serum). Cell suspensions were filtered and centrifuged at 1,500 rpm for 5 min at 4 °C. Cells were counted and resuspended in sterile PBS, and 200 μL (5 million cells) was injected intravenously (i.v.) into the tail vein of irradiated recipients. The following day, 100 μg of anti-Thy1 mAb (clone T24) was administered intraperitoneally to deplete residual host T cells. Chimeras were assessed for signs of disease and euthanized if they lost more than 10% of their peak body weight, according to the animal ethics guidelines.

Adoptive Transfer.

Spleens and lymph nodes were dissected, and cell suspensions were enriched for CD4+ or CD8+ T cells using AutoMACS column enrichment (Miltenyi Biotec). Cells (1 × 106) were then i.v. administered into Rag1−/− recipients, that were subsequently treated with CD4-depleting antibodies after injection with CD8+ T cells or with CD8-depleting Ab after injection with CD4+ T cells on days 0, 1, 7, and 14 to ensure depletion of residual contaminating cells of the unwanted T cell subset.

Histology.

Tissues were dissected and fixed in formalin, then embedded, sectioned, and stained with hematoxylin and eosin (H&E). Lymphocytic infiltration was scored as described (9, 40) with 0, 0.5, 1, 2, or 3 indicating none, trace, mild, moderate, or severe lymphocytic infiltration and tissue destruction, respectively. The scores from the analysis of the retina, salivary glands, lacrimal glands, thyroid glands, lung, liver, stomach, kidney, and pancreas were summed to derive the overall infiltration score.

Statistical Analysis.

Statistical comparisons were made using one-way ANOVA with multiple comparisons with Prism v.6.0 (GraphPad). P values of <0.05 were considered to indicate a statistically significant difference.

Further methods are supplied in .